IL10 and inflammatory bowel disease: Further, CD19hiCD1dhiCD5+ B cells produce IL10 and inhibit DSS-induced inflammatory bowel disease (22) and experimental Sjögren’s syndrome by suppressing Tfh cell responses (23).